Beringas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | 178 | 32,606 | 50,809 | 43,218 | 11,884 | 5,363 | 1,575 |
| Profit before tax | -885 | -1,759 | 3,496 | 2,876 | -26 | -4,067 | -4,868 | -4,962 |
| Net profit | -885 | -1,759 | 3,338 | 2,547 | -26 | -4,067 | -4,868 | -4,962 |
| Equity | 1,115 | -644 | 2,694 | 5,241 | 5,215 | 1,148 | -3,720 | -8,682 |
| Liabilities | 1,535 | 12,686 | 20,388 | 45,007 | 38,694 | 37,843 | 36,809 | 37,925 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 2,650 | 12,042 | 23,082 | 50,248 | 43,909 | 38,991 | 33,089 | 29,243 |
| Total assets | 2,650 | 12,042 | 23,082 | 50,248 | 43,909 | 38,991 | 33,089 | 29,243 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 2,417 | 469 | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | +18218.0% | +55.8% | -14.9% | -72.5% | -54.9% | -70.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -33.4% | -14.6% | 14.5% | 5.1% | -0.1% | -10.4% | -14.7% | -17.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -79.4% | - | 123.9% | 48.6% | -0.5% | -354.3% | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -988.2% | 10.2% | 5.0% | -0.1% | -34.2% | -90.8% | -315.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -988.2% | 10.7% | 5.7% | -0.1% | -34.2% | -90.8% | -315.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.4 | - | 7.6 | 8.6 | 7.4 | 33.0 | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 178 | 27,590 | 50,809 | 43,218 | 11,884 | 5,363 | 1,575 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Beringas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-16 | 2026-07-17 | 6.56 |
| 2023-07-19 | 2023-07-19 | 48.39 |
| 2023-06-16 | 2023-07-18 | 24.69 |
| 2023-05-16 | 2023-06-15 | 0.99 |
| 2022-12-16 | 2022-12-19 | 19.12 |
Beringas - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Beringas, UAB (code 304435519) is a private limited liability company engaged in the retail sale of pharmaceutical products. In 2025, the company generated €1.6K in revenue and recorded a net loss of €5.0K. Revenue continued to weaken, falling 70.6% year on year and 86.8% compared with 2023, while losses remained close to €5.0K. Because revenue was very small, the profitability ratio was heavily distorted and should be read as a sign of weak operating scale rather than a stable margin. The 2025 balance sheet showed total assets of €29.2K, liabilities of €37.9K and negative equity of €8.7K. Over the last three years, assets declined from €39.0K in 2023 to €29.2K in 2025, while equity moved from a small positive position to a negative balance. Liabilities stayed broadly stable in the €36.8K-€37.9K range. Revenue per employee stood at €1.6K in 2025, reflecting limited turnover.